Heart News and Research

RSS

Perfadex improves survival in lung tranplant patients: Study

A recently published study in The Journal of Heart and Lung Transplantation shows that the patients who are most seriously ill before lung tranplantation have better one-year survival when Perfadex is used as the preservation solution for donor lungs compared with UW solution. Furthermore, the patients who received lungs preserved in Perfadex ran a significantly lower risk of being affected by rejection reactions requiring treatment.

30 Aug 2010

Positron to host special ASNC 2010 symposium focusing on cardiac PET

Positron Corporation is pleased to announce K. Lance Gould M.D. as the keynote speaker for their upcoming cardiac PET symposium, held at the American Society of Nuclear Cardiology annual meeting, September 23-26 in Philadelphia, PA.

30 Aug 2010

Patients with atherothrombosis are at increased risk of ischemic events: Study

Clinical descriptors can assist clinicians in identifying patients with various stages of atherothrombosis (abnormal fatty deposits in an artery) who are at high-risk of future cardiovascular events, according to a study that will appear in the September 22 issue of JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology meeting in Stockholm.

30 Aug 2010

Royal Philips Electronics launches new iE33 xMATRIX cardiac ultrasound system

Royal Philips Electronics today announced the enhanced iE33 xMATRIX cardiac ultrasound system featuring a new ergonomic solution for more efficient adult echocardiograms, the X5-1 transducer. With this enhanced technology, Philips continues its tradition of simplified, patient-focused healthcare solutions by providing a more complete imaging solution.

From Philips Healthcare 30 Aug 2010

Closing ceremony of heart transplant recipient's 700 km bicycle tour across Canada

Media representatives are invited to join us for the closing ceremony of heart transplant recipient Sylvain Bédard's bicycle tour, to take place at the Montreal Heart Institute (MHI). Dr. Michel Pellerin, the cardiac surgeon who performed the operation, will present him with an official MHI shirt as well as a bouquet of flowers to mark his accomplishment: a tour across Canada, 700 kilometres of which were done on bicycle.

30 Aug 2010

Selective lowering of heart rate reduces risk of death and hospitalization: Study

The results of a major international study presented at the European Society of Cardiology Congress in Stockholm and published simultaneously in The Lancet show, for the first time, that selectively lowering heart rate with a novel medication, ivabradine, significantly reduces risk of death and hospitalization for patients with heart failure. This also resolves a longstanding debate about whether lowering heart rate itself can actually lower the risk of heart disease progression.

30 Aug 2010

Genetic variations in Y chromosome affect men's risk of coronary heart disease: Scientists

Scientists in the UK have shown that genetic variations in the Y chromosome affect a male's risk of coronary heart disease. It is well known that males have a higher incidence of coronary heart disease than females due, in part, to the Y chromosome they inherit from their fathers. To investigate the role of the Y chromosome further, a team from the University of Leicester carried out research to determine whether genetic variations in the Y-chromosome affect risk for males.

30 Aug 2010

MedCath to sell interest in Avera Heart Hospital of South Dakota to Avera McKennan

MedCath Corporation announced today it has entered into a definitive agreement to sell its subsidiary which is the indirect owner of a one-third ownership interest and management rights in Avera Heart Hospital of South Dakota to Avera McKennan. The transaction is expected to close in 45 to 90 days, subject to certain closing conditions.

30 Aug 2010

Low doses of n-3 fatty acids do not reduce overall rate of major cardiovascular events

Results from the Alpha Omega Trial, a multicentre, placebo-controlled trial in men and women following myocardial infarction (MI), suggest that low doses of n-3 fatty acids given in the form of enriched margarines do not reduce the overall rate of major cardiovascular events.

30 Aug 2010

RLY5016 potassium binder helps to regulate hyperkalemia in heart failure patients

Results from a recent phase 2b clinical trial may provide a new approach to managing excess potassium levels in patients with heart failure and heart failure with chronic kidney disease.

30 Aug 2010

SHIFT study finds Ivabradine reduces heart failure risk

Ivabradine, a selective If inhibitor already investigated for its effects in coronary artery disease and left ventricular dysfunction, significantly lowers the risk of heart failure, according to results of the SHIFT study (Systolic Heart failure treatment with the If inhibitor ivabradine Trial).

30 Aug 2010

Large clinical trial does not confirm benefits of erythropoieitin for first ST-elevation myocardial infarction

Results from the HEBE III study, a prospective, randomised, multicentre trial performed in seven centres in the Netherlands, suggest that the promising effects of erythropoieitin seen in previous smaller studies cannot be confirmed for the improvement of clinical outcome in patients with a first ST-elevation myocardial infarction.

30 Aug 2010

Registered nurses win landmark victories over issue of missed breaks

Washington State Nurses Association (WSNA), representing more than 16,000 registered nurses in Washington State, has won two landmark decisions for patient safety on the issue of missed breaks for registered nurses. Cases decided in Seattle and Spokane both affirm the employer's responsibility to provide uninterrupted rest breaks to nurses.

30 Aug 2010

Study finds bone marrow stem cell therapy improves efficacy in chronic heart failure

Bone marrow stem cell therapy improves ventricular performance, quality of life and survival in patients with chronic heart failure, according to results from the STAR-heart study.

30 Aug 2010

New research contradicts previous reports on blood-thinner clopidogrel

New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.

30 Aug 2010

New campaign to create awareness on atrial fibrillation related strokes

Mission 1 Million Getting to the Heart of Stroke launches today announcing a worldwide effort to help prevent as many as 1 million atrial fibrillation (AF) related strokes through increased awareness and understanding.

30 Aug 2010

ATOLL study favors enoxaparin over UFH for primary Percutaneous Coronary Intervention

The international ATOLL study sponsored by the Assistance Publique - Hopitaux de Paris showed that enoxaparin reduced the composite of death, complication of myocardial infraction, procedure failure or major bleeding by 17% in comparison with standard heparin death, recurrent acute coronary syndrome or urgent revascularisation. The results of the ATOLL study were presented at the hotline session of the annual European Cardiology Congress (ESC 2010) in Stockholm, Sweden.

30 Aug 2010

Jefferson scientists receive grant to study genetics of platelet gene expression

Scientists at Jefferson Medical College have received a four-year, $3 million National Institutes of Health grant funded by the National Heart, Lung and Blood Institute to study variations of platelet function, specifically, the genetics of platelet gene expression. The study aims to find data that can be translated into novel therapeutic strategies and develop better predictors of cardiovascular disease.

30 Aug 2010

Study finds BMI, thrombogenic factor increases cardiovascular risk

Although having a high body mass index (BMI) is a known risk factor for cardiovascular disease, researchers are only beginning to understand how BMI affects the physiological processes involved in the development of the disease. Now, a study of a subset of women in the Kronos Early Estrogen Prevention Study (KEEPS), suggests that as BMI increases, so do platelet reactivity and thrombogenic microvesicles and activated protein C in the blood-all of which contribute to the formation of atherothrombosis and associated cardiovascular events.

30 Aug 2010

Exmovere to release vital sign monitoring infant sleepwear

Exmovere Holdings, Inc., a biomedical engineering company, today announced plans to release vital sign monitoring infant sleepwear. Exmovere is in the advanced stages of taking to market a washable, conductive fabric-based biosensor pajama called "Exmobaby." Exmobaby is the first-ever baby garment developed for remote monitoring of heart rate, emotional state and behavior.

27 Aug 2010

Heart News and Research

Perfadex improves survival in lung tranplant patients: Study

Positron to host special ASNC 2010 symposium focusing on cardiac PET

Patients with atherothrombosis are at increased risk of ischemic events: Study

Royal Philips Electronics launches new iE33 xMATRIX cardiac ultrasound system

Closing ceremony of heart transplant recipient's 700 km bicycle tour across Canada

Selective lowering of heart rate reduces risk of death and hospitalization: Study

Genetic variations in Y chromosome affect men's risk of coronary heart disease: Scientists

MedCath to sell interest in Avera Heart Hospital of South Dakota to Avera McKennan

Low doses of n-3 fatty acids do not reduce overall rate of major cardiovascular events

RLY5016 potassium binder helps to regulate hyperkalemia in heart failure patients

SHIFT study finds Ivabradine reduces heart failure risk

Large clinical trial does not confirm benefits of erythropoieitin for first ST-elevation myocardial infarction

Registered nurses win landmark victories over issue of missed breaks

Study finds bone marrow stem cell therapy improves efficacy in chronic heart failure

New research contradicts previous reports on blood-thinner clopidogrel

New campaign to create awareness on atrial fibrillation related strokes

ATOLL study favors enoxaparin over UFH for primary Percutaneous Coronary Intervention

Jefferson scientists receive grant to study genetics of platelet gene expression

Study finds BMI, thrombogenic factor increases cardiovascular risk

Exmovere to release vital sign monitoring infant sleepwear

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News